| 发明名称 |
Use of EGFR transactivation inhibitors in human cancer |
| 摘要 |
The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction. |
| 申请公布号 |
AU2003219029(B2) |
申请公布日期 |
2008.09.11 |
| 申请号 |
AU20030219029 |
申请日期 |
2003.03.07 |
| 申请人 |
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V |
发明人 |
OLIVER FISCHER;AXEL ULLRICH;ANDREAS GSCHWIND;BEATRIX SCHAFER;MICHAEL LESERER |
| 分类号 |
A61K38/16;A61K31/16;A61K31/381;A61K38/18;A61K38/48;A61K38/55;C07K16/28 |
主分类号 |
A61K38/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
